Potkaní model deprese, behaviorální a imunitní změny po podání antipsychotik a antiepileptik

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F04%3A00010257" target="_blank" >RIV/00216224:14110/04:00010257 - isvavai.cz</a>

Výsledek na webu

—

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Rat model of depression, behavioural and immune changes after administration of antipsychotic and antiepileptic agents

Popis výsledku v původním jazyce

The olfactory bulbectomy (OB) in rats provides a well established animal model used for screening of drugs with a potential antidepressant activity. While currently some atypical neuroleptics and antiepileptics of the 3rd generation are reported from clinics to show mood stabilizing /antidepressant properties we studied effects of amisulpride (AMS), an atypical antipsychotic agent aproved at present for the treatment of at least dysthymia, and tiagabine (TGB), belonging to the newer antiepileptics, considering their activity in the OB model. Our second objective was to determine in the OB rat model, whether AMS and TGB influence the leukocyte phagocytic activity as a marker of cellular immune function. Only the results of the behavioural part of experiment resemble the reffered effects of classical antidepressants in the OB rats and indicate the hypothesized antidepressant activity of AMS and TGB in the present study.

Název v anglickém jazyce

Rat model of depression, behavioural and immune changes after administration of antipsychotic and antiepileptic agents

Popis výsledku anglicky

The olfactory bulbectomy (OB) in rats provides a well established animal model used for screening of drugs with a potential antidepressant activity. While currently some atypical neuroleptics and antiepileptics of the 3rd generation are reported from clinics to show mood stabilizing /antidepressant properties we studied effects of amisulpride (AMS), an atypical antipsychotic agent aproved at present for the treatment of at least dysthymia, and tiagabine (TGB), belonging to the newer antiepileptics, considering their activity in the OB model. Our second objective was to determine in the OB rat model, whether AMS and TGB influence the leukocyte phagocytic activity as a marker of cellular immune function. Only the results of the behavioural part of experiment resemble the reffered effects of classical antidepressants in the OB rats and indicate the hypothesized antidepressant activity of AMS and TGB in the present study.

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FR - Farmakologie a lékárnická chemie

OECD FORD obor

—

Projekt

—

Návaznosti

Z - Vyzkumny zamer (s odkazem do CEZ)

Rok uplatnění

2004

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Homeostasis

ISSN

0960-7560

e-ISSN

—

Svazek periodika

43

Číslo periodika v rámci svazku

1

Stát vydavatele periodika

IT - Italská republika

Počet stran výsledku

2

Strana od-do

45-46

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—